TEAL SANDER: Open Payments
NPI 1629526926 · GORHAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$550 in 25 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $657 · 2025 $550
Food & beverage: $550
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 2 | $63 |
| SOBI, INC | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $46 |
| Syndax Pharmaceuticals, Inc. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Rigel Pharmaceuticals, Inc. | 1 | $28 |
| TAIHO ONCOLOGY, INC. | 1 | $28 |
| Genentech USA, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: Onivyde, OJJAARA, KISQALI, TAVALISSE, LONSURF, Polivy, ICLUSIG, DARZALEX.
Industry payments across KS — which companies pay providers there.
